Natus Executive and Leadership Team

Chris Landon, the Chief Executive Officer at Natus, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the global expansion of medical device solutions, the Chief Executive Officer ensures alignment between product development and the evolving needs of the neurological and sensory healthcare sectors. This leadership role involves managing high-level relationships with stakeholders and driving sustainable growth across international markets. By prioritizing innovation in newborn care and neurosurgical treatments, Chris Landon directly influences the company's market position. Landon maintains a rigorous focus on operational excellence, ensuring that all business units contribute to the mission of improving patient outcomes. Through constant evaluation of market trends and competitive landscapes, the Chief Executive Officer secures the financial health and strategic trajectory of the enterprise, fostering a culture of precision and clinical reliability in every diagnostic and treatment solution provided.

Michael Owens, the Chief Technology Officer at Natus, architects the technical roadmap for advanced diagnostic and monitoring equipment. Overseeing the research and development of hardware and software for epilepsy and sleep disorder management, the Chief Technology Officer drives the integration of cutting-edge engineering into clinical workflows. This leadership role involves managing the engineering teams responsible for the next generation of neuro-diagnostic tools. By optimizing product performance and reliability, Michael Owens directly impacts the efficacy of patient screening and tracking systems. Owens maintains a focus on technical scalability, ensuring that all technological advancements meet stringent regulatory standards while addressing the complex requirements of neurosurgical treatments. Through the continuous refinement of sensory system diagnostic platforms, the Chief Technology Officer supports the company's commitment to technological leadership, ensuring that every innovation provides clinicians with the precise data necessary for effective patient care and long-term health management.

Linda Quinlivan, the Vice President, Strategy & Clinical Affairs & Chief Marketing Officer at Natus, directs the strategic positioning and clinical validation of the company's medical device portfolio. Overseeing the alignment of clinical research with market demand, the Vice President, Strategy & Clinical Affairs & Chief Marketing Officer ensures that all product launches address critical gaps in hearing impairment and neuromuscular disease treatment. This leadership role involves managing global marketing initiatives and communicating the clinical value of diagnostic solutions to healthcare providers. By synthesizing clinical data into actionable market insights, Linda Quinlivan directly influences the adoption rates of new medical technologies. Quinlivan maintains a focus on evidence-based growth, ensuring that strategic initiatives reflect the latest advancements in sensory and neurological science. Through the coordination of clinical affairs and marketing, the Vice President, Strategy & Clinical Affairs & Chief Marketing Officer strengthens the brand's reputation for excellence in patient-centered medical care.

Nathan Rucker, the Chief Operations Officer at Natus, directs the manufacturing, supply chain, and logistics functions required to deliver medical device solutions worldwide. Overseeing the production of equipment for newborn care and neurological monitoring, the Chief Operations Officer ensures that manufacturing processes maintain the highest standards of quality and efficiency. This leadership role involves managing the global distribution network to ensure timely delivery of critical diagnostic tools to hospitals and clinics. By optimizing the supply chain and reducing operational bottlenecks, Nathan Rucker directly impacts the company's ability to meet the high demand for neurosurgical and sensory treatment products. Rucker maintains a focus on operational scalability, ensuring that production capacity aligns with the company's growth objectives. Through the rigorous management of manufacturing resources and logistics, the Chief Operations Officer supports the seamless delivery of life-improving medical technology, ensuring that every facility receives the necessary equipment to provide superior patient care.